Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Simultaneous pharmacokinetic and pharmacodynamic modeling

W A Colburn

    Journal of Pharmacokinetics and Biopharmaceutics
    |June 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Thalidomide dose proportionality assessment following single doses to healthy subjects.

    Journal of clinical pharmacology·2001
    Same author

    Pharmacokinetic/pharmacodynamic modeling in drug research and development.

    Journal of clinical pharmacology·2001
    Same author

    Optimizing the use of biomarkers, surrogate endpoints, and clinical endpoints for more efficient drug development.

    Journal of clinical pharmacology·2001
    Same author

    Hemoglobin and methemoglobin concentrations after large-dose infusions of diaspirin cross-linked hemoglobin.

    Anesthesia and analgesia·2001
    Same author

    Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women.

    Biopharmaceutics & drug disposition·2000
    Same author

    An evolution of drug development and clinical pharmacology during the 20th century.

    Journal of clinical pharmacology·2000

    This study rigorously tested and extended a compartmental model for characterizing drug pharmacokinetics and pharmacodynamics. The flexible modeling approach was validated for diverse drug concentration-effect relationships.

    Area of Science:

    • Pharmacology
    • Pharmacometrics
    • Mathematical Modeling

    Background:

    • The Sheiner et al. compartmental model offers a framework for simultaneous pharmacokinetic (PK) and pharmacodynamic (PD) characterization.
    • Understanding PK/PD relationships is crucial for optimizing drug therapy and development.

    Purpose of the Study:

    • To rigorously test and extend the previously proposed compartmental model for PK/PD characterization.
    • To derive and evaluate PK/PD equations for various standard and alternative compartmental models.
    • To assess the versatility and flexibility of the modeling approach using simulations and curve-fitting.

    Main Methods:

    • Derivation of pharmacokinetic and pharmacodynamic equations for multiple compartmental models.
    • Development of alternative models linking peripheral compartment drug concentrations to effect.

    Related Experiment Videos

  • Application of simulation and curve-fitting techniques to evaluate model performance.

    • Main Results:

    • The compartmental modeling approach demonstrated versatility and flexibility in characterizing PK/PD relationships.
    • Validation through simulation and curve-fitting confirmed the utility of the extended models.
    • Identified specific scenarios and limitations where the modeling procedure is most effective.

    Conclusions:

    • The extended compartmental modeling approach provides a robust and adaptable tool for PK/PD analysis.
    • The study highlights the practical utility of these models in drug development and clinical pharmacology.
    • Further research can explore the application of these models to complex drug-disease interactions.